Asthma severity categorization using a claims-based algorithm or pulmonary function testing

Journal of Asthma

Volumn 46, Issue 1, 2009, Pages 67-72

  Birnbaum, H G ^a   Ivanova, J I ^a,f   Yu, A P ^a   Hsieh, M ^a   Seal, B ^b   Emani, S ^c,d   Rosiello, R ^d   Colice, G L ^e  

^a ANALYSIS GROUP   (United States)

^b SANOFI   (France)

^c MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^d Fallon Clinic   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

^f NONE   (United States)

Author keywords

Asthma severity; Database analyses; Persistent asthma; Pulmonary function test results

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; ASTHMA; CHILD; CLINICAL PRACTICE; DATA BASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG COST; DRUG MEGADOSE; EMERGENCY CARE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HOSPITAL COST; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT CODING; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; AMBULATORY CARE; ECONOMICS; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; MEDICAL RECORD; MIDDLE AGED; PATHOPHYSIOLOGY; UNITED STATES;

ADOLESCENT; ADULT; ALGORITHMS; AMBULATORY CARE; ASTHMA; CHILD; EMERGENCY SERVICE, HOSPITAL; HEALTH EXPENDITURES; HOSPITALIZATION; HUMANS; MASSACHUSETTS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PRESCRIPTION DRUGS; RESPIRATORY FUNCTION TESTS; YOUNG ADULT;

EID: 60549104277     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802503099     Document Type: Article

References (25)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI, 2006.
2. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma - Update on Selected Topics 2002.. National Heart, Lung and Blood Institute. 2002.
3. US Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. Asthma Prevalence, Health Care Use and Mortality, 2002. Available at: http://www.cdc.gov/nchs/products/ pubs/hestats/asthmahtm. Visited March 3, 2008.
4. Colice G, Wu EQ, Birnbaum H, Daher M, Marynchenko MB, Varghese S. Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. J Occup Environ Med 2006; 48:794-802.
5. Birnbaum HG, Berger WE, Greenberg PE, Holland M, Auerbach R, Atkins KM, Wanke LA. Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol 2002; 109:264-270.
6. Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to degree of severity. Eur Respir J 1998; 12:1322-1326.
7. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity. Eur Respir J 2002; 19:61-67.
8. Cisternas MG, Bland PD, Yen IH, Katz PP, Earnest G, Eisner MD, Shiboski S, Yelin EH. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003; 111:1212-1218.
9. Colice G, Wu EQ, Birnbaum H, Daher M, Maryna BM. Use of inhaled corticosteroids and health care costs in mild persistent asthma. J Asthma 2007; 44:-479.
10. Colice GL, Yu AP, Ivanova JI, Hsieh M, Birnbaum HG, Lage MJ, Brewster C. Costs and resource use of mild persistent asthma patients initiated on controller therapy. J Asthma 2008; 45:1-7.
11. Schatz M, Nakahiro R, Crawford W, Mendoza G, Mosen D, Stibolt TB. Asthma quality-of-care markers using administrative data. Chest 2005; 128:1968-1973.
12. Schatz M, Zeiger RS, Vollmer WM, Mosen D, Mendoza G, Aper AJ, Stibolt TB, Leong A, Johnson MS, Cook EF. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest 2006; 130:43-50.
13. Schatz M, Zeiger RS, Vollmer WM, Mosen D, Aper AJ, Stibolt TB, Leong A, Johnson MS, Mendoza G, Cook EF. Validation of a β-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 2006; 117:995-1000.
14. National Committee for Quality Assurance. Use of appropriate medications for people with asthma. HEDIS 2005, Vol 2. Technical Specifications. Washington, DC.
15. Berger WE, Leforreta AP, Blaiss MS, Schneider EC, Luskin AT, Stempel DA, Suissa S, Goodman DC, Stoloff SW, Chapman JA, Sullivan SD, Vollmer B, Weiss KB. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 2004; 93:538-545.
16. Gelfand EW, Colice GL, Fromer L, Bunn WB, Davies TJ. Use of the health plan employer data and information set for measuring and improving the quality of asthma care. Ann Allergy Asthma Immunol 2006; 97:298-305.
17. Cabana MC, Slish KK, Nan B, Clark NM. Limits of the HedIS criteria in determining asthma severity for children. Pediatrics 2004; 114:1049-1055.
18. Mosen DM, Macy E, Schatz M, Mendoza G, Stibolt TB, McGaw J, Goldstein J, Bellows J. Howwell do the HEDIS asthma inclusion criteria identify persistent asthma? Am J Manag Care 2005; 11:650-654.
19. Fuhlbrigge AL, Carey VJ, Finkelstein JA, Lozano P, Inui T, Weiss ST, Weiss KB. Validity of the HEDIS criteria to identify children with persistent asthma and sustained high utilization. Am J Manag Care 2005; 11:325-330.
20. Leidy NK, Paramore LC, Watrous M, Doyle J, Zeiger RS. Development of an algorithm for estimating asthma severity from an administrative cost database. Value Health 1999; 2:394.
21. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric Reference Values from a Sample of the General U.S. Population. Am J Respir Crit Care Med 1999; 159:179-187.
22. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung and Blood Institute. 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.pdf. Visited May 16, 2008.
23. Colice GL, Vanden Burgt J, Song J, Stampone P, Thompson PJ. Categorizing asthma severity. Am J Respir Crit Care Med 1999; 160:1962-1967.
24. Thomas M, Cleland J, Price D. Database studies in asthma pharmacoeconomics. Expert Opin Pharmacother 2003; 4:351-358.
25. Lee S, Kirking DM, Erickson SR. Methods of measuring asthma severity and influence on patient assignment. Ann Allergy Asthma Immunol 2003; 91:449-454.